Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155216667635
Abstract: Immunotherapy with checkpoint inhibitors has revolutionized the management of metastatic melanoma. These checkpoints, namely the cytotoxic T lymphocyte antigen 4 and the programmed T cell death 1 receptor, possess an inhibitory effect on the T… read more here.
Keywords: syndrome lymphadenopathy; sarcoidosis like; checkpoint inhibitors; like syndrome ... See more keywords